View Older Stories View More Recent Stories

Mar 24, 2020 08:30AM ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
Mar 2, 2020 08:31AM ANI Pharma (ANIP) Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
Mar 2, 2020 08:30AM ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
Feb 27, 2020 08:30AM ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020
Feb 12, 2020 08:30AM ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL
Jan 24, 2020 08:30AM ANI Announces Launch of Tolterodine Extended-Release Capsules
Jan 16, 2020 08:32AM ANI Pharma (ANIP) Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
Jan 16, 2020 08:30AM ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
Jan 14, 2020 08:30AM ANI Announces Launch of Paliperidone Extended-Release Tablets
Jan 9, 2020 08:32AM ANI Pharma (ANIP) Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals
Jan 9, 2020 08:30AM ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd.
Dec 18, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
Nov 26, 2019 08:30AM ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference
Nov 6, 2019 08:30AM ANI Pharmaceuticals Reports Third Quarter Results
Oct 31, 2019 08:30AM ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias
Oct 29, 2019 08:30AM ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business
Oct 3, 2019 08:31AM ANI Pharma (ANIP) Reports Positive Clinical Results from Cortrophin Gel Cortisol Response Study
Oct 3, 2019 08:30AM ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study
Oct 2, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg
Sep 11, 2019 08:32AM ANI Pharma (ANIP) Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL
Sep 11, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL
Aug 7, 2019 08:30AM ANI Pharmaceuticals Reports Second Quarter Results
Jun 25, 2019 08:35AM ANI Pharma (ANIP) Announces Launch of Ranitidine Capsules
Jun 25, 2019 08:30AM ANI Pharmaceuticals Announces Launch of Ranitidine Capsules
Jun 20, 2019 10:33AM ANI Pharma (ANIP) Announces FDA Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml
Jun 20, 2019 10:30AM ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml
Jun 18, 2019 08:03AM ANI Pharma (ANIP) Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis
Jun 18, 2019 08:00AM ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.
Jun 12, 2019 08:30AM ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference
May 9, 2019 08:30AM ANI Pharmaceuticals Reports First Quarter 2019 Results and Reaffirms Guidance
Apr 15, 2019 08:38AM ANI Pharma (ANIP) Expands Injectable Portfolio with Distribution Agreement
Apr 15, 2019 08:30AM ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product
Mar 27, 2019 08:34AM ANI Pharma (ANIP) Announces Two Generic Product Launches
Mar 27, 2019 08:30AM ANI Pharmaceuticals Announces Two Generic Product Launches
Feb 27, 2019 08:30AM ANI Pharmaceuticals Reports Record Full Year and Fourth Quarter 2018 Results and Provides 2019 Guidance
Dec 27, 2018 04:30PM ANI Pharmaceuticals Secures Refinancing for Convertible Debt Due December 2019 and Enters Amended Five-Year $265 Million Senior Secured Credit Facility
Dec 7, 2018 08:00AM ANI Pharmaceuticals Enters into Separate Privately Negotiated Agreements with Certain Holders of its Convertible Notes
Nov 6, 2018 08:30AM ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance
Oct 16, 2018 09:00AM ANI Announces Launch of Authorized Generic of Brethine®
Oct 4, 2018 08:33AM ANI Pharma (ANIP) Announces Launch of Authorized Generic of Atacand HCT Tablets
Oct 4, 2018 08:30AM ANI Pharmaceuticals Announces Launch of Authorized Generic of Atacand HCT® Tablets
Sep 27, 2018 08:30AM ANI Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
Aug 8, 2018 01:00PM ANI Pharmaceuticals to Present at New Time at the Canaccord Genuity 38th Annual Growth Conference
Aug 7, 2018 08:30AM ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2018 Results and Updates Guidance
Aug 6, 2018 08:30AM ANI Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference
Jun 27, 2018 08:06AM ANI Pharma (ANIP) Reports Launch of Cholestyramine for Oral Suspension USP
Jun 27, 2018 08:00AM ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
Jun 5, 2018 08:37AM ANI Pharma (ANIP) Appoints Thomas J. Haughey, David B. Nash and Patrick D. Walsh to Board
Jun 5, 2018 08:30AM ANI Shareholders Elect Three New Members to the Board of Directors
May 8, 2018 08:30AM ANI Pharmaceuticals Reports First Quarter 2018 Results and Reaffirms Guidance
View More Recent Stories View Older Stories